Eglė Domarkienė - Company finances
|
EUR
|
2024
From: 2024-05-13
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|
|
Financial data
|
||
| Sales revenue | 19,750 | 44,145 |
| Profit before tax | 1,870 | -1,777 |
| Net profit | 1,870 | -1,777 |
| Equity | 1,890 | 113 |
| Liabilities | 0 | 0 |
| Non-current assets | 0 | 0 |
| Current assets | 1,890 | 113 |
| Total assets | 1,890 | 113 |
|
Taxes paid
|
||
| STI taxes | - | 3 |
|
Financial indicators
|
||
| Revenue change y/y | - | +123.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 98.9% | -1572.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 98.9% | -1572.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 9.5% | -4.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 9.5% | -4.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Eglė Domarkienė - Social security debts
The company had no debts to Sodra
Eglė Domarkienė - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Eglė Domarkienė is: 0 €
| From | To | Overdue, € |
|---|---|---|
| 2026-08-28 | 2026-09-02 | 0.1 |
| 2026-07-30 | 2026-08-23 | 0.28 |
| 2026-06-28 | 2026-07-07 | 0.15 |
| 2026-04-30 | 2026-04-30 | 6.0 |
| 2026-01-29 | 2026-02-21 | 2.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Egle Domarkiene, MB (company code 306761061) is a small partnership engaged in medical specialists activities. In the latest financial year, 2025, revenue increased to EUR 44.1K from EUR 19.8K in 2024, which represents growth of 123.5%. However, this higher turnover did not translate into improved profitability. The company reported net profit of EUR 1.9K in 2024, but net loss of EUR 1.8K in 2025, and the profit margin moved from 9.5% to -4.0%. The two-year trend therefore shows rising sales alongside a clear weakening in earnings. The balance sheet also remained very small: total assets were EUR 113 at the end of 2025, with equity at the same level, compared with EUR 1.9K for both assets and equity in 2024. Because the year-end capital base was extremely small, return measures are heavily distorted and should be interpreted with caution. Overall, 2025 was a year of strong revenue expansion but negative bottom-line performance.